ABOUT ADHARTAS

Bringing life science companies based in Europe, US and Asia together

Adhartas was formed in March 2015. It is a company registered in UK and based near Edinburgh, Scotland.

Adhartas is a healthcare advisory services company that specialises in bringing life science companies based in Europe, US and Asia together using an experienced network of associates who have been in the healthcare industries for many years.

The Company is a business advisory company in the pharmaceutical and healthcare field offering the following business pathways:

New Products or Formulations:

Working with client companies who are developing new products or formulations and require financial and co-development partners to take the project(s) to market.

New Products & Technologies

Assisting companies plan their clinical, regulatory and manufacturing strategy for new products and technologies.

MORE Areas of Specialty

Clinical Trial Programmes

Managing and monitoring the full clinical trial programmes for client companies in conjunction with CRO’s.

IP

Identifying, managing and maximising the IP protection and exploitation of clients' products and portfolios.

Manufacturing Sites

Identifying suitable EU GMP approved manufacturing sites in EU, US or Asia for clients without their own capacity.

EU Regulations

Project managing the strategic plan to gain products, formulations or manufacturing site approval by EU regulatory agencies.

Marketing Partners

Assisting companies in the EU find marketing partners for their technologies in South East Asia, India, China and Japan.

Asian and African Domestic Markets

Assisting companies in regulated markets in Asia and Africa identify and in-license novel products and technologies for marketing in their domestic markets.

SME Corporate Strategy

Formulating corporate strategy for SME’s in the pharmaceutical and healthcare industry together with a “network” of experienced consultants.

Learn more

South East Asia, India, China & Japan

Working with companies based in South East Asia, India, China and Japan to identify, assess and in-license novel products and technologies which are in the final stages of development and close to market.

Meet the EXecutive TEam